Next Article in Journal
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma
Next Article in Special Issue
Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT
Previous Article in Journal
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14, 2595
Previous Article in Special Issue
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
 
 
Article

Article Versions Notes

Cancers 2023, 15(11), 2926; https://doi.org/10.3390/cancers15112926
Action Date Notes Link
article xml file uploaded 26 May 2023 09:12 CEST Original file -
article xml uploaded. 26 May 2023 09:12 CEST Update https://www.mdpi.com/2072-6694/15/11/2926/xml
article pdf uploaded. 26 May 2023 09:12 CEST Version of Record https://www.mdpi.com/2072-6694/15/11/2926/pdf
article supplementary file uploaded. 26 May 2023 09:12 CEST - https://www.mdpi.com/2072-6694/15/11/2926#supplementary
article html file updated 26 May 2023 09:14 CEST Original file -
article html file updated 26 May 2023 09:15 CEST Update https://www.mdpi.com/2072-6694/15/11/2926/html
Back to TopTop